Literature DB >> 7734997

Identifying patients with hypercholesterolemia. More than one blood sample is needed.

M Speechley1, S McNair, A Leffley, M Bass.   

Abstract

OBJECTIVE: To compare the use of one and two blood samples for diagnosing hypercholesterolemia
DESIGN: A test-retest substudy conducted as part of a randomized control trial designed to compare the effectiveness of different counseling strategies for lowering serum cholesterol, dietary fat, and dietary cholesterol in patients with moderate hypercholesterolemia.
SETTING: Thirty urban family practices. PARTICIPANTS: One hundred forty-two patients provided two blood samples for total cholesterol (TC) level determination at two different times (test results were being used as an eligibility criterion for enrollment in the main trial). MAIN OUTCOME MEASURES: Number of subjects correctly classified to cholesterol risk category (normal < 6.2 mmol/L; moderate 6.2 to 6.9 mmol/L; high > 6.9 mmol/L) on the basis of one TC value and on the average of two TC values.
RESULTS: Overall misclassification rate on initial TC level was 22.5%. Overall false-positive rate was 19.0%, but false-positive rate for those initially assigned to the high category was 50%. Overall false-negative rate was 3.5%. Misclassification rates did not differ statistically on the basis of age, sex, blood pressure, smoking status, family history of coronary heart disease, presence of diabetes, obesity, the laboratory used, or whether the patient had fasted before giving blood.
CONCLUSIONS: Single TC levels are too unreliable for diagnostic purposes, even if the subjects fast before testing. Family physicians should base their treatment decisions on the average of two cholesterol readings taken at different times 1 to 8 weeks apart.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734997      PMCID: PMC2146253     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  7 in total

1.  Interlaboratory variability in serum lipid measurements.

Authors:  R F Kahn; R S McCord
Journal:  Fam Pract Res J       Date:  1991-12

2.  Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  P W Connelly; D R MacLean; L Horlick; B O'Connor; A Petrasovits; J A Little
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

3.  Serum cholesterol variations in individual patients.

Authors:  C M Grossman
Journal:  Atherosclerosis       Date:  1988-06       Impact factor: 5.162

Review 4.  Individual variation in serum cholesterol levels.

Authors:  D M Hegsted; R J Nicolosi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Variability in individual serum cholesterol response to change in diet.

Authors:  D R Jacobs; J T Anderson; P Hannan; A Keys; H Blackburn
Journal:  Arteriosclerosis       Date:  1983 Jul-Aug

6.  Within-person fluctuations of serum cholesterol and lipoproteins.

Authors:  M Mogadam; S W Ahmed; A H Mensch; I D Godwin
Journal:  Arch Intern Med       Date:  1990-08

7.  The variability of serum cholesterol measurements: implications for screening and monitoring.

Authors:  S G Thompson; S J Pocock
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

  7 in total
  1 in total

1.  The effect of chairside chronic disease screenings by oral health professionals on health care costs.

Authors:  Kamyar Nasseh; Barbara Greenberg; Marko Vujicic; Michael Glick
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.